PPARGC1A and breast carcinoma: Moreover, patients with breast cancer showed no significant difference in OS between low- and high-expressing cells of CD36 (log-rank P = 0.75), PPARGC1A (log-rank P = 0.65), and CREBBP (log-rank P = 0.37).